JP
Jajula Poojitha
About Jajula Poojitha
Data last updated:
Jajula Poojitha is a Director at Loriox India Pharmaceuticals Private Limited (since 2025). The company operates in Business Services. Loriox India Pharmaceuticals Private Limited reported revenue of ₹93,884 (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Loriox India Pharmaceuticals Private Limited U74999TG2018PTC122983 | Director | 16 Jan 2025 | 2018 | ₹93,884 (FY 2024) | Active |
Board colleagues of Jajula Poojitha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mamatha Gandham | 10478221 | Loriox India Pharmaceuticals Private Limited | Director |
| Srujana Kothakapu | 10865487 | Loriox India Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jajula Poojitha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jajula Poojitha
Jajula Poojitha currently holds 1 directorship: Loriox India Pharmaceuticals Private Limited (Director, since 16 Jan 2025, revenue ₹93,884 (FY 2024)).
Jajula Poojitha was first appointed on 16 Jan 2025 as Director at Loriox India Pharmaceuticals Private Limited.
The current boards of Jajula Poojitha's companies include Mamatha Gandham (Loriox India Pharmaceuticals Private Limited), Srujana Kothakapu (Loriox India Pharmaceuticals Private Limited).